XML 35 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Investment Holding Level 3 (Tables)
 9 Months Ended
Sep. 30, 2016
Schedule of Investments [Abstract]  
Realized Gain (Loss) on Investments [Table Text Block]
Net Realized Capital Gains (Losses)
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(Before-tax)
2016
2015
 
2016
2015
Gross gains on sales
$
47

$
33

 
$
138

$
217

Gross losses on sales
(6
)
(33
)
 
(66
)
(181
)
Net OTTI losses recognized in earnings
(12
)
(24
)
 
(23
)
(32
)
Valuation allowances on mortgage loans
—

—

 
—

(4
)
Periodic net coupon settlements on credit derivatives
1

2

 
1

5

Results of variable annuity hedge program
 
 
 
 
 
GMWB derivatives, net
6

(32
)
 
(8
)
(35
)
Macro hedge program
(64
)
51

 
(98
)
24

Total results of variable annuity hedge program
(58
)
19

 
(106
)
(11
)
Modified coinsurance reinsurance contracts
(1
)
3

 
(48
)
29

Other, net [1]
(2
)
(22
)
 
(41
)
(41
)
Net realized capital losses
$
(31
)
$
(22
)
 
$
(145
)
$
(18
)

[1]
Primarily consists of changes in value of non-qualifying derivatives and transactional foreign currency revaluation gains (losses). For the three months ended September 30, 2016 and 2015, transactional foreign currency revaluation gains (losses) were $(10) and $(17), respectively, and related to yen denominated fixed payout annuity liabilities, while there were also gains on the related hedging instruments of $13 and $8, respectively, used to hedge the foreign currency exposure. For the nine months ended September 30, 2016 and 2015, the transactional foreign currency revaluation losses were $(118) and $(1), respectively, while there were also gains (losses) on the related hedging instruments of $109 and $(23), respectively.
Net realized capital gains and losses from investment sales are reported as a component of revenues and are determined on a specific identification basis. Before tax, net gains (losses) on sales and impairments previously reported as unrealized gains (losses) in AOCI were $28 and $49, respectively, for the three and nine months ended September 30, 2016, and $(24) and $10 for the three and nine months ended September 30, 2015, respectively. Proceeds from sales of AFS securities totaled $1.8 billion and $5.7 billion, respectively, for the three and nine months ended September 30, 2016, and $2.3 billion and $7.9 billion for three and nine months ended September 30, 2015, respectively.
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Table Text Block]
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(Before-tax)
2016
2015
 
2016
2015
Balance as of beginning of period
$
(181
)
$
(270
)
 
$
(211
)
$
(296
)
Additions for credit impairments recognized on [1]:
 
 
 
 
 
Securities not previously impaired
(2
)
—

 
(10
)
(2
)
Securities previously impaired
(9
)
(12
)
 
(10
)
(12
)
Reductions for credit impairments previously recognized on:
 
 
 
 
 
Securities that matured or were sold during the period
11

49

 
37

54

Securities due to an increase in expected cash flows
3

10

 
16

32

Securities the Company made the decision to sell or more likely than not will be required to sell
—

—

 
—

1

Balance as of end of period
$
(178
)
$
(223
)
 
$
(178
)
$
(223
)
[1]
These additions are included in the net OTTI losses recognized in earnings in the Condensed Consolidated Statements of Operations.
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentration of Credit Risk
The Company aims to maintain a diversified investment portfolio including issuer, sector and geographic stratification, where applicable, and has established certain exposure limits, diversification standards and review procedures to mitigate credit risk. The Company had no investment exposure to any credit concentration risk of a single issuer greater than 10% of the Company’s stockholder's equity, other than the U.S. government and certain U.S. government agencies as of September 30, 2016 and December 31, 2015. For further discussion of concentration of credit risk, see the Concentration of Credit Risk section in Note 3 - Investments and Derivatives of Notes to Consolidated Financial Statements in the Company’s 2015 Form 10-K Annual Report.
Schedule of Unrealized Loss on Investments [Table Text Block]
Unrealized Losses on AFS Securities
The following tables present the Company’s unrealized loss aging for AFS securities by type and length of time the security was in a continuous unrealized loss position.
 
September 30, 2016
 
Less Than 12 Months
 
12 Months or More
 
Total
 
Amortized Cost
Fair Value
Unrealized Losses
 
Amortized Cost
Fair Value
Unrealized Losses
 
Amortized Cost
Fair Value
Unrealized Losses
ABS
$
112

$
111

$
(1
)
 
$
273

$
245

$
(28
)
 
$
385

$
356

$
(29
)
CDOs [1]
281

281

(1
)
 
540

536

(4
)
 
821

817

(5
)
CMBS
294

291

(3
)
 
114

109

(5
)
 
408

400

(8
)
Corporate
802

784

(18
)
 
393

369

(24
)
 
1,195

1,153

(42
)
Foreign govt./govt. agencies
43

42

(1
)
 
6

5

(1
)
 
49

47

(2
)
Municipal
10

10

—

 
—

—

—

 
10

10

—

RMBS
86

86

—

 
240

234

(6
)
 
326

320

(6
)
U.S. Treasuries
189

188

(1
)
 
—

—

—

 
189

188

(1
)
Total fixed maturities, AFS
1,817

1,793

(25
)
 
1,566

1,498

(68
)
 
3,383

3,291

(93
)
Equity securities, AFS [2]
27

25

(2
)
 
37

34

(3
)
 
64

59

(5
)
Total securities in an unrealized loss position
$
1,844

$
1,818

$
(27
)
 
$
1,603

$
1,532

$
(71
)
 
$
3,447

$
3,350

$
(98
)
 
 
December 31, 2015
 
Less Than 12 Months
 
12 Months or More
 
Total
 
Amortized Cost
Fair Value
Unrealized Losses
 
Amortized Cost
Fair Value
Unrealized Losses
 
Amortized Cost
Fair Value
Unrealized Losses
ABS
$
387

$
385

$
(2
)
 
$
271

$
239

$
(32
)
 
$
658

$
624

$
(34
)
CDOs [1]
608

602

(6
)
 
500

493

(5
)
 
1,108

1,095

(11
)
CMBS
655

636

(19
)
 
99

94

(5
)
 
754

730

(24
)
Corporate
4,880

4,696

(184
)
 
363

322

(41
)
 
5,243

5,018

(225
)
Foreign govt./govt. agencies
144

136

(8
)
 
30

27

(3
)
 
174

163

(11
)
Municipal
179

174

(5
)
 
—

—

—

 
179

174

(5
)
RMBS
280

279

(1
)
 
230

223

(7
)
 
510

502

(8
)
U.S. Treasuries
963

950

(13
)
 
8

8

—

 
971

958

(13
)
Total fixed maturities, AFS
8,096

7,858

(238
)
 
1,501

1,406

(93
)
 
9,597

9,264

(331
)
Equity securities, AFS [2]
83

79

(4
)
 
44

37

(7
)
 
127

116

(11
)
Total securities in an unrealized loss position
$
8,179

$
7,937

$
(242
)
 
$
1,545

$
1,443

$
(100
)
 
$
9,724

$
9,380

$
(342
)

[1]
Unrealized losses exclude the change in fair value of bifurcated embedded derivatives within certain securities, for which changes in fair value are recorded in net realized capital gains (losses).
[2]
As of September 30, 2016 and December 31, 2015, excludes equity securities, FVO, which are included in equity securities, AFS on the Condensed Consolidated Balance Sheets.
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
The following tables present the carrying value of the Company’s mortgage loans by region and property type.
Mortgage Loans by Region
 
September 30, 2016
 
December 31, 2015
 
Carrying Value
Percent of Total
 
Carrying Value
Percent of Total
East North Central
$
54

1.9%
 
$
66

2.3%
East South Central
14

0.5%
 
14

0.5%
Middle Atlantic
210

7.4%
 
210

7.2%
New England
138

4.8%
 
163

5.6%
Pacific
910

31.9%
 
933

32.0%
South Atlantic
585

20.5%
 
579

19.8%
West South Central
128

4.5%
 
125

4.3%
Other [1]
817

28.5%
 
828

28.3%
Total mortgage loans
$
2,856

100.0%
 
$
2,918

100.0%
[1]
Primarily represents loans collateralized by multiple properties in various regions.
The following table presents the carrying value of the Company’s commercial mortgage loans by LTV and DSCR.
Commercial Mortgage Loans Credit Quality
 
September 30, 2016
 
December 31, 2015
Loan-to-value
Carrying Value
Avg. Debt-Service Coverage Ratio
 
Carrying Value
Avg. Debt-Service Coverage Ratio
Greater than 80%
$
15

0.45x
 
$
15

0.91x
65% - 80%
265

2.15x
 
280

1.78x
Less than 65%
2,576

2.59x
 
2,623

2.54x
Total commercial mortgage loans
$
2,856

2.53x
 
$
2,918

2.45x
Mortgage Loans
Mortgage Loan Valuation Allowances
The Company’s security monitoring process reviews mortgage loans on a quarterly basis to identify potential credit losses. Commercial mortgage loans are considered to be impaired when management estimates that, based upon current information and events, it is probable that the Company will be unable to collect amounts due according to the contractual terms of the loan agreement. Criteria used to determine if an impairment exists include, but are not limited to: current and projected macroeconomic factors, such as unemployment rates, and property-specific factors such as rental rates, occupancy levels, LTV ratios and debt service coverage ratios (“DSCR”). In addition, the Company considers historic, current and projected delinquency rates and property values. These assumptions require the use of significant management judgment and include the probability and timing of borrower default and loss severity estimates. In addition, projections of expected future cash flows may change based upon new information regarding the performance of the borrower and/or underlying collateral such as changes in the projections of the underlying property value estimates.
For mortgage loans that are deemed impaired, a valuation allowance is established for the difference between the carrying amount and the Company’s share of either (a) the present value of the expected future cash flows discounted at the loan’s effective interest rate, (b) the loan’s observable market price or, most frequently, (c) the fair value of the collateral. A valuation allowance has been established for either individual loans or as a projected loss contingency for loans with an LTV ratio of 90% or greater and after consideration of other credit quality factors, including DSCR. Changes in valuation allowances are recorded in net realized capital gains and losses. Interest income on impaired loans is accrued to the extent it is deemed collectible and the loans continue to perform under the original or restructured terms. Interest income ceases to accrue for loans when it is probable that the Company will not receive interest and principal payments according to the contractual terms of the loan agreement. Loans may resume accrual status when it is determined that sufficient collateral exists to satisfy the full amount of the loan and interest payments as well as when it is probable cash will be received in the foreseeable future. Interest income on defaulted loans is recognized when received.
 
September 30, 2016
 
December 31, 2015
 
Amortized Cost [1]
Valuation Allowance
Carrying Value
 
Amortized Cost [1]
Valuation Allowance
Carrying Value
Total commercial mortgage loans
$
2,875

$
(19
)
$
2,856

 
$
2,937

$
(19
)
$
2,918

[1]
Amortized cost represents carrying value prior to valuation allowances, if any.
As of September 30, 2016, and December 31, 2015, the carrying value of mortgage loans associated with the valuation allowance was $31 and $39, respectively. There were no mortgage loans held-for-sale as of September 30, 2016, and December 31, 2015. As of September 30, 2016, loans within the Company’s mortgage loan portfolio that have had extensions or restructurings other than what is allowable under the original terms of the contract are immaterial.
Mortgage Loans by Property Type
 
September 30, 2016
 
December 31, 2015
 
Carrying Value
Percent of Total
 
Carrying Value
Percent of Total
Commercial
 
 
 
 
 
Agricultural
$
16

0.6%
 
$
16

0.5%
Industrial
830

29.1%
 
829

28.4%
Lodging
25

0.9%
 
26

0.9%
Multifamily
568

19.9%
 
557

19.1%
Office
663

23.2%
 
729

25.0%
Retail
614

21.5%
 
650

22.3%
Other
140

4.8%
 
111

3.8%
Total mortgage loans
$
2,856

100.0%
 
$
2,918

100.0%
The following table presents the activity within the Company’s valuation allowance for mortgage loans. These loans have been evaluated both individually and collectively for impairment. Loans evaluated collectively for impairment are immaterial.
 
Nine Months Ended September 30,
 
2016
2015
Balance, beginning of period
$
(19
)
$
(15
)
(Additions)/Reversals
—

(4
)
Deductions
—

—

Balance, end of period
$
(19
)
$
(19
)
Gain (Loss) on Investments [Table Text Block]
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
2015
 
2016
2015
Credit impairments
$
11

$
12

 
$
20

$
14

Intent-to-sell impairments
—

8

 
1

14

Impairments on equity securities
1

4

 
2

4

Total impairments
$
12

$
24

 
$
23

$
32
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]
Available-for-Sale Securities
The following table presents the Company’s AFS securities by type.
 
September 30, 2016
December 31, 2015
 
Cost or Amortized Cost
Gross Unrealized Gains
Gross Unrealized Losses
Fair Value
Non-Credit OTTI [1]
Cost or Amortized Cost
Gross Unrealized Gains
Gross Unrealized Losses
Fair Value
Non-Credit OTTI [1]
ABS
$
1,061

$
17

$
(29
)
$
1,049

$
—

$
864

$
16

$
(34
)
$
846

$
—

CDOs [2]
1,156

57

(5
)
1,209

—

1,354

67

(11
)
1,408

—

CMBS
2,182

95

(8
)
2,269

(2
)
1,936

52

(24
)
1,964

(3
)
Corporate
13,939

1,696

(42
)
15,593

—

14,425

975

(225
)
15,175

(3
)
Foreign govt./govt. agencies
306

34

(2
)
338

—

328

14

(11
)
331

—

Municipal
1,104

185

—

1,289

—

1,057

80

(5
)
1,132

—

RMBS
1,731

57

(6
)
1,782

—

1,468

43

(8
)
1,503

—

U.S. Treasuries
1,740

357

(1
)
2,096

—

2,127

184

(13
)
2,298

—

Total fixed maturities, AFS
23,219

2,498

(93
)
25,625

(2
)
23,559

1,431

(331
)
24,657

(6
)
Equity securities, AFS [3]
89

15

(5
)
99

—

178

11

(11
)
178

—

Total AFS securities
$
23,308

$
2,513

$
(98
)
$
25,724

$
(2
)
$
23,737

$
1,442

$
(342
)
$
24,835

$
(6
)
[1]
Represents the amount of cumulative non-credit OTTI losses recognized in OCI on securities that also had credit impairments. These losses are included in gross unrealized losses as of September 30, 2016 and December 31, 2015.
[2]
Gross unrealized gains (losses) exclude the fair value of bifurcated embedded derivatives within certain securities. Subsequent changes in value are recorded in net realized capital gains (losses).
[3]
Excluded equity securities, FVO, with a cost and fair value of $293 and $281 as of December 31, 2015. The Company held no equity securities, FVO as of September 30, 2016.
Investments Classified by Contractual Maturity Date [Table Text Block]
The following table presents the Company’s fixed maturities, AFS, by contractual maturity year.
 
September 30, 2016
 
December 31, 2015
Contractual Maturity
Amortized Cost
Fair Value
 
Amortized Cost
Fair Value
One year or less
$
694

$
701

 
$
953

$
974

Over one year through five years
4,522

4,706

 
4,973

5,075

Over five years through ten years
3,715

3,958

 
3,650

3,714

Over ten years
8,158

9,951

 
8,361

9,173

Subtotal
17,089

19,316

 
17,937

18,936

Mortgage-backed and asset-backed securities
6,130

6,309

 
5,622

5,721

Total fixed maturities, AFS
$
23,219

$
25,625

 
$
23,559

$
24,657


Estimated maturities may differ from contractual maturities due to security call or prepayment provisions. Due to the potential for variability in payment speeds (i.e. prepayments or extensions), mortgage-backed and asset-backed securities are not categorized by contractual maturity.
Schedule of Variable Interest Entities [Table Text Block]
Consolidated VIEs
The following table presents the carrying value of assets and liabilities, and the maximum exposure to loss relating to the VIEs for which the Company is the primary beneficiary. Creditors have no recourse against the Company in the event of default by these VIEs nor does the Company have any implied or unfunded commitments to these VIEs. The Company’s financial or other support provided to these VIEs is limited to its collateral or investment management services and original investment. Since December 31, 2015, the Company has disposed of the VIEs for which it was the primary beneficiary.
 
September 30, 2016
 
December 31, 2015
 
Total Assets
Total Liabilities  [1]
Maximum Exposure to Loss [2]
 
Total Assets
Total Liabilities  [1]
Maximum Exposure to Loss [2]
Investment funds [3]
$
—

$
—

$
—

 
$
52

$
11

$
42

Limited partnerships and other alternative investments [4]
—

—

—

 
2

1

1

Total
$
—

$
—

$
—

 
$
54

$
12

$
43

[1]
Included in other liabilities on the Company’s Condensed Consolidated Balance Sheets.
[2]
The maximum exposure to loss represents the maximum loss amount that the Company could recognize as a reduction in net investment income or as a realized capital loss and is the cost basis of the Company’s investment.
[3]
Total assets included in fixed maturities, FVO, short-term investments, and equity, AFS on the Company’s Condensed Consolidated Balance Sheets.
[4]
Total assets included in limited partnerships and other alternative investments on the Company’s Condensed Consolidated Balance Sheets.